{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:26:37Z","timestamp":1761060397769},"reference-count":27,"publisher":"Impact Journals, LLC","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,12]]},"DOI":"10.18632\/oncotarget.19623","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T00:02:23Z","timestamp":1501200143000},"page":"65983-65996","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic factors and outcomes of primary transitional cell carcinoma of the ureter: a population-based study"],"prefix":"10.18632","volume":"8","author":[{"given":"Tao","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Urology, Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuojun","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renfang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Urology, Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuixing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Urology, Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.eururo.2015.06.044","article-title":"European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update","volume":"68","author":"Shariat","year":"2015","journal-title":"Eur Urol"},{"key":"2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","article-title":"Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature","volume":"62","author":"Zigeuner","year":"2012","journal-title":"Eur Urol"},{"key":"3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.eururo.2016.09.035","article-title":"Systematic review on the fate of the remnant urothelium after radical cystectomy","volume":"71","author":"Kassouf","year":"2017","journal-title":"Eur Urol"},{"key":"4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.urology.2016.05.033","article-title":"Survival comparison between endoscopic and surgical management for patients with upper tract urothelial cancer: a matched propensity score analysis using surveillance, epidemiology and end results-medicare data","volume":"95","author":"Strope","year":"2016","journal-title":"Urology"},{"key":"5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5527\/wjn.v5.i2.158","article-title":"Upper tract urothelial carcinoma: paradigm shift towards nephron sparing management","volume":"5","author":"Schwartz","year":"2016","journal-title":"World J Nephrol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.6004\/jnccn.2016.0131","article-title":"NCCN Guidelines insights: bladder cancer, version 2.2016","volume":"14","author":"Herr","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"7","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Wood","year":"2009","journal-title":"Cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1016\/j.ejca.2009.06.016","article-title":"Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients","volume":"45","author":"Karakiewicz","year":"2009","journal-title":"Eur J Cancer"},{"key":"9","first-page":"4051","article-title":"Effect of adjuvant radiotherapy on survival in patients with locoregional urothelial malignancies of the upper urinary tract","volume":"36","author":"Martin","year":"2016","journal-title":"Anticancer Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"38175","DOI":"10.1038\/srep38175","article-title":"Adjuvant radiotherapy for locally advanced upper tract urothelial carcinoma","volume":"6","author":"Lai","year":"2016","journal-title":"Sci Rep"},{"key":"11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-5347(01)62763-0","article-title":"Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy","volume":"160","author":"Sagalowsky","year":"1998","journal-title":"J Urol"},{"key":"12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-5347(01)66563-7","article-title":"Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?","volume":"155","author":"Housset","year":"1996","journal-title":"J Urol"},{"key":"13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0959-8049(99)00012-X","article-title":"Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study","volume":"35","author":"Mirimanoff","year":"1999","journal-title":"Eur J Cancer"},{"key":"14","first-page":"333","article-title":"Adjuvant radiotherapy for stage III\/IV urothelial carcinoma of the upper tract","volume":"34","author":"DO Ahn","year":"2014","journal-title":"Anticancer Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1002\/cncr.26172","article-title":"Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study","volume":"117","author":"Bigot","year":"2011","journal-title":"Cancer"},{"key":"16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.juro.2009.05.011","article-title":"Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration","volume":"182","author":"Kikuchi","year":"2009","journal-title":"J Urol"},{"key":"17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.21037\/tau.2016.03.23","article-title":"Why are upper tract urothelial carcinoma two different diseases?","volume":"5","author":"Nyirady","year":"2016","journal-title":"Transl Androl Urol"},{"key":"18","first-page":"261","article-title":"Upper urinary tract disease: what we know today and unmet needs","volume":"4","author":"Shariat","year":"2015","journal-title":"Transl Androl Urol"},{"key":"19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.urolonc.2016.11.017","article-title":"Utilization of perioperative systemic chemotherapy in upper tract urothelial carcinoma","volume":"35","author":"Yuh","year":"2017","journal-title":"Urol Oncol"},{"key":"20","article-title":"High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy","volume":"32","author":"Kutikov","year":"2014","journal-title":"Urol Oncol"},{"key":"21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11934-013-0307-z","article-title":"The role of systemic chemotherapy in management of upper tract urothelial cancer","volume":"14","author":"Margulis","year":"2013","journal-title":"Curr Urol Rep"},{"key":"22","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1442-2042.2012.03110.x","article-title":"Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades","volume":"19","author":"Margulis","year":"2012","journal-title":"Int J Urol"},{"key":"23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.urolonc.2016.11.018","article-title":"Neoadjuvant and adjuvant chemotherapy use in upper tract urothelial carcinoma","volume":"35","author":"Park","year":"2017","journal-title":"Urol Oncol"},{"key":"24","article-title":"The effect of tumor location on oncologic outcomes in patients with upper urinary tract urothelial carcinoma stratified by pathologic stage","volume":"34","author":"Pu","year":"2016","journal-title":"Urol Oncol"},{"key":"25","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cncr.29936","article-title":"Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer","volume":"122","author":"Ly","year":"2016","journal-title":"Cancer"},{"key":"26","unstructured":"Roupret, Zigeuner, Palou, Boehle, Kaasinen, Sylvester, Babjuk, Oosterlinck. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract. [European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2015 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract]. [Article in Spanish]. Actas Urol Esp. 2015; 36:2-14."},{"key":"27","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Compton","year":"2010","journal-title":"Ann Surg Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T10:47:18Z","timestamp":1589194038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":27,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2017,9,12]]}},"alternative-id":["19623","29029487"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.19623","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]}}}